BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 183.50
+1.60 (0.88%)
Jul 10, 2026, 4:08 PM HKT
BeOne Medicines AG Stock Forecast
Stock Price Forecast
According to 16 analysts polled by S&P Global, BeOne Medicines AG stock has a consensus rating of "Strong Buy" and an average price target of $254.01. The average 1-year stock price forecast is 38.43% higher than the current stock price, while the lowest is $212.62 (+15.87%) and the highest is $298.47 (+62.65%).
Price Target: $254.01 (+38.43%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for BeOne Medicines AG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 14 | 14 | 14 | 14 | 13 | 13 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 17 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Huafu Securities No rating | Huafu Securities | Buy Maintains $297.44 | Buy | Maintains | $297.44 | +62.09% | Jul 7, 2026 |
Unknown Analyst UBS No rating | UBS | Buy Maintains $279.00 → $273.60 | Buy | Maintains | $279.00 → $273.60 | +49.10% | Jul 1, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $250.00 | Buy | Maintains | $250.00 | +36.24% | Jun 3, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains $271.80 | Buy | Maintains | $271.80 | +48.12% | Jun 2, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $243.80 | Buy | Maintains | $243.80 | +32.86% | May 21, 2026 |
Financial Forecast
Revenue This Year
45.25B
from 37.37B
Increased by 21.09%
Revenue Next Year
51.90B
from 45.25B
Increased by 14.70%
EPS This Year
3.49
from 1.33
Increased by 162.66%
EPS Next Year
5.37
from 3.49
Increased by 53.76%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 47.2B | ||
| Avg | 45.3B | ||
| Low | 43.4B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 26.4% | ||
| Avg | 21.1% | ||
| Low | 16.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.10 | ||
| Avg | 3.49 | ||
| Low | 2.94 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 283.7% | ||
| Avg | 162.7% | ||
| Low | 121.1% |